Table 3.
Most frequent (>10%) drug-resistance mutations in HIV-1 protease, according to origin of sample.
| Mutation | All samples | BA | SP | RS | CE | RJ | ES |
|---|---|---|---|---|---|---|---|
| 10I | 17.7 | 19.2 | 19.4 | 27.6 | 10.0 | 11.8 | 20.3 |
| 10V | 10.6 | 13.0 | 13.6 | 6.5 | 8.4 | 4.6 | 11.6 |
| 20R | 15.0 | 14.3 | 11.7 | 26.0 | 13.6 | 10.5 | 16.7 |
| 36I | 47.0 | 47.3 | 49.5 | 53.7 | 46.8 | 40.1 | 46.2 |
| 46I | 15.3 | 19.2 | 8.7 | 26.8 | 8.4 | 9.9 | 13.9 |
| 54V | 12.6 | 13.9 | 13.6 | 30.9 | 5.2 | 5.3 | 12.0 |
| 60E | 11.0 | 9.2 | 8.7 | 0.0 | 9.2 | 21.7 | 16.3 |
| 62V | 24.4 | 23.7 | 26.2 | 0.0 | 24.8 | 37.5 | 28.7 |
| 71V | 14.1 | 20.8 | 12.6 | 28.5 | 12.0 | 5.9 | 0.0 |
| 90M | 12.6 | 15.9 | 11.7 | 23.6 | 8.4 | 2.0 | 10.8 |
| 93L | 23.3 | 21.0 | 29.1 | 3.3 | 22.4 | 24.3 | 36.3 |